TNBCs are highly heterogeneous due to their classification on three missing growth factor receptors (estrogen receptor (ERα), progesterone receptor (PR), human epidermal growth factor 2 receptor (HER2)); tumor heterogeneity can account for differing responses to the same chemotherapies [3]. Here, PGR is linked to neoplasm.